Curanex Pharmaceuticals 

$5.16
9
+$0.22+4.45%Friday 20:00
+$0.00+0%Friday 20:00After hours

Statistics

Day High
5.3
Day Low
5.29
52W High
14.12
52W Low
3.58
Volume
258
Avg. Volume
-
Mkt Cap
8.09M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2023
2024
2025
0Revenue
-4.23MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.
Show More
CEO
Jun Liu
Employees
6
Country
United States
ISIN
US23126K3041

Listings

0 Comments

Share your thoughts

FAQs

What is Curanex Pharmaceuticals stock price today?▼
The current price of CURX is $5.16 USD — it has increased by +4.45% in the past 24 hours. Watch Curanex Pharmaceuticals stock price performance more closely on the chart.
What is Curanex Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Curanex Pharmaceuticals stocks are traded under the ticker CURX.
Is Curanex Pharmaceuticals stock price growing?▼
CURX stock has risen by +12.17% compared to the previous week, the month change is a +9.32% rise, over the last year Curanex Pharmaceuticals has showed a -61.95% decrease.
What is Curanex Pharmaceuticals market cap?▼
Today Curanex Pharmaceuticals has the market capitalization of 8.09M
What is Curanex Pharmaceuticals revenue for the last year?▼
Curanex Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Curanex Pharmaceuticals net income for the last year?▼
CURX net income for the last year is -4.23M USD.
How many employees does Curanex Pharmaceuticals have?▼
As of November 2, 2026, the company has 6 employees.
In which sector is Curanex Pharmaceuticals located?▼
Curanex Pharmaceuticals operates in the Health & Wellness sector.
When did Curanex Pharmaceuticals complete a stock split?▼
The last stock split for Curanex Pharmaceuticals was on August 20, 2026 with a ratio of 1:20.
Where is Curanex Pharmaceuticals headquartered?▼
Curanex Pharmaceuticals is headquartered in JERICHO, United States.